Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Epifanio Sánchez"'
Autor:
John Barja-Ore, Natalia Valverde-Espinoza, Elena Campomanes-Pelaez, Nilda Alaya Rodríguez, Epifanio Sánchez Garavito, Julio Silva Ramos, Nieves Zuñiga-Olivera
Publikováno v:
Revista Cubana de Medicina Militar, Vol 50, Iss 4, Pp e02101644-e02101644 (2021)
Introduction: COVID-19 in pregnant women has been a challenge in maternal care, since it could increase the risk of suffering from some obstetric diseases and negative perinatal results. Objective: To describe the epidemiological characteristics and
Externí odkaz:
https://doaj.org/article/11f57060a8db494e881719c17b2c8f1e
Autor:
Dylan B Tierney, Molly F Franke, Mercedes C Becerra, Félix A Alcántara Virú, César A Bonilla, Epifanio Sánchez, Dalia Guerra, Maribel Muñoz, Karim Llaro, Eda Palacios, Lorena Mestanza, Rocío M Hurtado, Jennifer J Furin, Sonya Shin, Carole D Mitnick
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108035 (2014)
Sputum cultures are an important tool in monitoring the response to tuberculosis treatment, especially in multidrug-resistant tuberculosis. There has, however, been little study of the effect of treatment regimen composition on culture conversion. We
Externí odkaz:
https://doaj.org/article/ba1320f4f9c64d2db742045af821ca63
Autor:
Sonya S. Shin, Jennifer J. Furin, Felix Alcántara, Jaime Bayona, Epifanio Sánchez, Carole D. Mitnick
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 4, Pp 687-688 (2006)
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34%
Externí odkaz:
https://doaj.org/article/657052fc7b2745a2b6d3d6a4bcea8bd0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Farrukh, Ismat Lotia, Lachenal, Nathalie, Adenov, Malik M, Ahmed, Saman, Algozhin, Yerkebulan, Coutisson, Sylvine, Garavito, Epifanio Sánchez, Hewison, Catherine, Holtzman, David, Huerga, Helena, Janmohamed, Aleeza, Khan, Palwasha Y, Jacques, Gamarly Leblanc, Lomtadze, Nino, Melikyan, Nara, Mitnick, Carole D, Mussabekova, Gulnaz, Osso, Elna, Perea, Sara, Putri, Fauziah Asnely
Publikováno v:
Clinical Infectious Diseases; 1/15/2024, Vol. 78 Issue 1, p144-148, 5p
Autor:
Helena Huerga, Uzma Khan, Mathieu Bastard, Carole D Mitnick, Nathalie Lachenal, Palwasha Y Khan, Kwonjune J Seung, Nara Melikyan, Saman Ahmed, Michael L Rich, Francis Varaine, Elna Osso, Makhmujan Rashitov, Naseem Salahuddin, Gocha Salia, Epifanio Sánchez, Armine Serobyan, Muhammad Rafi Siddiqui, Dri Grium Tefera, Dmitry Vetushko, Lusine Yeghiazaryan, David Holtzman, Shirajul Islam, Andargachew Kumsa, Gamarly Jacques Leblanc, Olga Leonovich, Shahid Mamsa, Mohammad Manzur-ul-Alam, Zaw Myint, Shrivani Padayachee, Molly F Franke, Catherine Hewison
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(8)
Background Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resistant tuberculosis (MDR/RR-TB) has raised concerns about a potentially poor risk-benefit ratio. Yet this combination is an important alternative for pat
Autor:
Epifanio Sánchez Garavito, Geraint Davies, Gustavo E. Velásquez, Elna Osso, Meredith B Brooks, Leonid Lecca, Carole D. Mitnick, Julia Coit, Dante Elmo Vargas Vasquez, Dylan B. Tierney, Kwonjune J. Seung, Roger Calderon, Judith Jimenez, Karen Tintaya, Henry Pertinez, Charles A. Peloquin
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: We examined whether increased rifampin doses could shorten standard therapy for tuberculosis without increased toxicity. Objectives: To assess the differences across three daily oral doses of rifampin in change in elimination rate of Mycob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd0a680e4032f8075b72e27ed3d301e
Autor:
Geraint Davies, Karen Tintaya, Judith Jimenez, Epifanio Sánchez Garavito, Carole D. Mitnick, Meredith B Brooks, Leonid Lecca, Julia Coit, Gustavo E. Velásquez, Charles A. Peloquin, Roger Calderon, Elna Osso
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 199:1167-1168
Autor:
Meredith B. Milstein, Geraint Davies, Julia Coit, Leonid Lecca, Epifanio Sánchez Garavito, Dante Elmo Vargas Vasquez, Marcello Pagano, Carmen Contreras, Elna Osso, David Coleman, Kwonjune J. Seung, Roger Calderon, Charles A. Peloquin, Denis A. Mitchison, Carole D. Mitnick
Publikováno v:
BMC Infectious Diseases
BACKGROUND: Evidence has existed for decades that higher doses of rifampin may be more effective, but potentially more toxic, than standard doses used in tuberculosis treatment. Whether increased doses of rifampin could safely shorten treatment remai
Autor:
Epifanio Sánchez, Jennifer Furin, Keith Joseph, Michael Rich, Anne Hyson, Sonya Shin, Felix Alcántara
Publikováno v:
Chest. 125:974-980
Between January 1999 and December 2000, 125 patients in Lima, Peru were enrolled in individualized treatment for multidrug-resistant tuberculosis (MDR-TB). Hypokalemia was observed to be an important adverse effect encountered in this cohort.To ident